Alzheimer Disease  >>  Octagam (intravenous normal human immunoglobulin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Octagam (intravenous normal human immunoglobulin) / Octapharma
NCT00812565 / 2007-007134-19: Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease

Completed
2
58
US
Placebo, octagam 10%, IVIG
Octapharma
Alzheimer's Disease
09/10
09/10

Download Options